Novo Nordisk A/S

NYSE: NVO · Real-Time Price · USD
64.35
-1.80 (-2.72%)
At close: May 16, 2025, 3:59 PM

Novo Nordisk A/S Revenue

Novo Nordisk A/S reported an annual revenue of $290.4B, reflecting a 25.03% growth. For the quarter ending March 31, 2025, Novo Nordisk A/S generated $78.09B in revenue.
Revenue (ttm)
$290.4B
Revenue Growth
25.03%
Price / Sales Ratio
9.5
Revenue / Employee
$3.75M
Employees
77,406
Market Cap
281.38B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.